scholarly article | Q13442814 |
P356 | DOI | 10.1126/SCIENCE.181.4095.161 |
P953 | full work available at URL | https://syndication.highwire.org/content/doi/10.1126/science.181.4095.161 |
P698 | PubMed publication ID | 4711734 |
P2093 | author name string | R. L. Marcus | |
L. Aurelian | |||
H. J. Davis | |||
B. Schumann | |||
P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
Journal of the National Cancer Institute | Q400279 | ||
Journal of Immunology | Q3521441 | ||
Journal of General Virology | Q6295245 | ||
British journal of venereal diseases | Q26853878 | ||
Virus-specific, labile, nonvirion antigen in herpesvirus-infected cells | Q33692828 | ||
Immunofluorescent detection of herpesvirus antigens in exfoliated cells from human cervical carcinoma | Q33702525 | ||
Specific carcinoembryonic antigens of the human digestive system | Q36267788 | ||
A specific complement-fixing antigen present in SV 40 tumor and transformed cells. | Q36402854 | ||
A DNA fragment of Herpes simplex 2 and its transcription in human cervical cancer tissue | Q37503989 | ||
Oncogenic viruses | Q39893130 | ||
A search for viruses in smegma, premalignant and early malignant cervical tissues. The isolation of Herpesviruses with distinct antigenic properties | Q43838354 | ||
HSV-2 antigens absent from biopsied cervical tumor cells: a model consistent with latency. | Q43861320 | ||
Soluble membrane antigens of lip and cervical carcinomas: reactivity with antibody for herpesvirus nonvirion antigens | Q45064707 | ||
The proteins specified by herpes simplex virus. I. Time of synthesis, transfer into nuclei, and properties of proteins made in productively infected cells | Q45823492 | ||
Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera. | Q46219789 | ||
Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. | Q54059451 | ||
The association of genital herpesvirus with cervical atypia and carcinoma in situ | Q68609803 | ||
Herpesvirus Type 2 in the Male Genitourinary Tract | Q69452357 | ||
Herpesvirus Type 2 Isolated from Cervical Tumor Cells Grown in Tissue Culture | Q70610304 | ||
The association of herpesvirus type 2 and carcinoma of the uterine cervix | Q72525319 | ||
P433 | issue | 4095 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | antibody | Q79460 |
Human herpesvirus 2 | Q18965147 | ||
neoplasm antigens | Q76832457 | ||
P304 | page(s) | 161-164 | |
P577 | publication date | 1973-07-01 | |
1973-07-13 | |||
P1433 | published in | Science | Q192864 |
P1476 | title | Antibody to HSV-2 Induced Tumor Specific Antigens in Serums from Patients with Cervical Carcinoma | |
P478 | volume | 181 |
Q67252372 | A herpesvirus antigen in human premalignant and malignant cervical biopsies and explants |
Q40007062 | Adenine arabinoside (ARA-A) blocked HSV-2 infected human skin fibroblasts as targets for the detection of serum mediated and cellular cytotoxicity in patients with cervical carcinoma |
Q45798051 | An ELISA technique to detect IgG antibody to the early herpes simplex virus type 2 (HSV-2) antigen AG-4 in HSV-2 patients |
Q72452519 | Antibody to AG-4 and survival of carcinoma of cervix patients |
Q35875067 | Are viruses important in carcinogenesis? |
Q36310277 | Carcinogen-transformed human cells are inhibited from entry into S phase by fusion to senescent cells but cells transformed by DNA tumor viruses overcome the inhibition |
Q39322378 | Changeable Lymphocytotoxic Antibody Activity in Patients with Cervical Carcinoma |
Q40078023 | Clinical Implications of Immunity to Oncogenic Viruses |
Q40112263 | Complement-dependent cytotoxic antibodies in the course of cervical carcinoma |
Q36423561 | Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients |
Q33658604 | Confirmation of herpes simplex virus type 2 infections in herpes-like genital lesions by a simple complement-fixation test |
Q45800202 | Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization |
Q40224149 | Detection of herpes simplex virus tumor-associated antigen in uterine cervical cancer tissue |
Q45792167 | Estimation of type-specific neutralizing antibody to herpes simplex virus type 2 in uterine cervical cancer patients by a new absorption method |
Q40127117 | Genital cancer and viruses |
Q40069351 | Herpes Simplex Virus Tumor-Associated Antigens in Cancer Patients |
Q38064337 | Herpes Simplex Virus-Host Cell Interactions |
Q39511005 | Herpes simplex type 2 virus and cervical neoplasia |
Q35058245 | Herpes simplex virus 2 (HSV-2) infected cell proteins are among the most dominant antigens of a live-attenuated HSV-2 vaccine |
Q37216457 | Herpes simplex virus and carcinoma of the cervix |
Q70937601 | Herpesvirus type 2 in adenocarcinoma of the uterine cervix: A possible association |
Q68695055 | Herpesviruses and cancer |
Q37769410 | Immunity, Herpes Simplex Virus, and Cervical Carcinoma |
Q37401442 | Immunodiagnostic potential of a virus-coded, tumor-associated antigen (AG-4) in cervical cancer |
Q35230200 | Impact of Human Papillomavirus Research on the Histopathologic Concepts of Genital Neoplasms |
Q40127046 | Induction of latent Herpes simplex virus type 2 infection in human cervical epithelial cells in vitro |
Q72452511 | Intra-ductal infusion of mono-octanoin for common duct stones |
Q35875063 | Neoplasms, differentiations and mutations |
Q36497452 | Neoplastic transformation of cultured Syrian hamster embryo cells by DNA of herpes simplex virus type 2 |
Q36613643 | Oncogenic properties of human viruses |
Q70971695 | Pathogenesis of Carcinoma of the Uterine Cervix |
Q39519038 | Proteins of herpes virus type 2 IV. Leukocyte inhibition responses to type common antigen(s) in cervix cancer and recurrent herpetic infections |
Q45803205 | Purification of herpes simplex virus tumor associated antigen from human kidney carcinoma |
Q35362555 | Quiescent human diploid cells can inhibit entry into S phase in replicative nuclei in heterodikaryons |
Q72871018 | Responses of mouse spleen morphology to the growth of subcutaneously injected virally transformed cells |
Q72883978 | The Relationship of Herpesvirus to Carcinoma of the Prostate |
Q37219533 | The association of Herpes simplex virus and cervical cancer: A review |
Q27472761 | The association of viruses with urveal melanoma |
Q39946854 | The causative role of herpesvirus type 2 in cervical cancer |
Q34068579 | The latent herpes simplex virus |
Q36365172 | Tumorigenic transformation induced by a specific fragment of DNA from herpes simplex virus type 2 |
Q37401493 | Venereal factors in human cervical cancer.Evidence from marital clusters |
Q36985344 | Viruses and cancer of the lower genital tract |
Q40127125 | “The herpesvirus hypothesis”—Are Koch's postulates satisfied? |